Document is current
Any future updates will be listed below
-
Authors
Sait, Sameer Farouk
Giantini-Larsen, Alexandra M.
Tringale, Kathryn R.
Souweidane, Mark M.
Karajannis, Matthias A. https://orcid.org/0000-0002-7151-6528
-
Funding
Funding for this research was provided by:
NIH/NCI (P30 CA008748)
- License Information
-
More Information
Article History
Accepted: 13 February 2023
First Online: 7 March 2023
Declarations
:
: Dr. Karajannis reports grants from Y-mAbs Therapeutics (research support) and personal fees from Bayer, AstraZeneca, QED Therapeutics, CereXis, Recursion, Alexion, Cardinal Health, and Medscape (medical advisory board and/or consultant). Dr. Tringale reports grants from Hopper Belmont Foundation and RSNA Resident Grant, as well as honoraria from GT Medical Technologies. Drs. Farouk Sait and Souweidane report no relationships, conditions, or circumstances that present a potential conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
